Plasma viscosity, fibrinogen and the metabolic syndrome: effect of obesity and cardiorespiratory fitness

The association between both plasma viscosity and fibrinogen concentration with clustering of metabolic risk markers was examined within a cross-sectional study of employed middle-aged men. Analyses were performed on a subsample of 629 non-smokers (46.7 ± 7.8 years) without diabetes. The effect of o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood coagulation & fibrinolysis 2000-01, Vol.11 (1), p.71-78
Hauptverfasser: Carroll, S, Cooke, C B, Butterly, R J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 78
container_issue 1
container_start_page 71
container_title Blood coagulation & fibrinolysis
container_volume 11
creator Carroll, S
Cooke, C B
Butterly, R J
description The association between both plasma viscosity and fibrinogen concentration with clustering of metabolic risk markers was examined within a cross-sectional study of employed middle-aged men. Analyses were performed on a subsample of 629 non-smokers (46.7 ± 7.8 years) without diabetes. The effect of obesity and cardiorespiratory fitness on these haemorheological parameters and their association with the metabolic syndrome was also investigated. The cohort was grouped by the number of metabolic markers present. Metabolic markers included high-density lipoprotein-cholesterol (< 1.13 mmol/l), triglycerides (≥ 1.805 mmol/l), glucose (≥ 5.5 mmol/l) and diastolic blood pressure (≥ 90 mmHg). The age-adjusted odds ratio for hyperviscosity (≥ 1.67 mPa/s) was 2.08 [95% confidence interval (CI), 1.06-4.05; P = 0.031] for the subjects with the metabolic syndrome (three or more metabolic markers) when compared with those with no metabolic abnormalities. The comparable age-adjusted odds ratio for hyperfibrinogenaemia (≥ 3.47 g/l) was non-significantly higher at 1.69 (95% CI, 0.87-3.27; P = 0.119). The mean age-adjusted plasma viscosity level and the prevalence of hyperviscosity increased significantly from 1.629 to 1.692 mPa/s (P = 0.0005) and from 21.0 to 36.0% with accumulating metabolic markers (P = 0.006). Plasma viscosity and fibrinogen concentration both increased with higher quartiles of skinfolds (P = 0.003 and P = 0.01, respectively) following adjustment for age, lipids and leucocyte count. Plasma viscosity was also significantly lower with higher levels of predicted maximum oxygen consumption ( o2max) (P = 0.0005). The odds ratio for hyperviscosity in subjects with the metabolic syndrome as compared with those with no metabolic markers was attenuated following adjustment for age, sum of skinfolds and predicted maximum oxygen consumption ( o2max) (1.44; 95% CI, 0.72-2.90; P = 0.307). These cross-sectional results suggest that plasma viscosity is associated with increased clustering of metabolic markers in middle-aged men of high socio-economic status. Obesity and poor cardiorespiratory fitness may be important in the development of haemorheological abnormalities associated with the metabolic syndrome.
doi_str_mv 10.1097/00001721-200011010-00008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70923657</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70923657</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3858-740473ccc129f669452b1c1716c95b69decd8546172c341a6cb96d4b7874c2593</originalsourceid><addsrcrecordid>eNpVkU1v1DAQhi0EotuFv4B8qDiRYsdfMTdU0Q-pEhzgbDnOhDV14sX2ttp_j9PdFvBlrNHzzuh9ByFMyTklWn0k9VHV0qZdPpRQ0iyt7gVaUa5YIxRjL9GKaKEa0TJxgk5z_lUJxjv1Gp1QIvUiW6HNt2DzZPG9zy5mX_Yf8Oj75Of4E2Zs5wGXDeAJiu1j8A7n_TykOMEnDOMIruA44tjDonyknU2Djwny1idbYtrXcWWGnN-gV6MNGd4e6xr9uPzy_eK6uf16dXPx-bZxrBNdozipBpxztNWjlJqLtqeOKiqdFr3UA7ihE1xW945xaqXrtRx4rzrFXSs0W6P3h7nbFH_vIBczVWsQgp0h7rJRRLdM1oDWqDuALsWcE4xmm_xk095QYpaUzVPK5jnlx1ZXpe-OO3b9BMM_wkOsFTg7AjY7G8ZkZ-fzX65Vi8uK8QP2EEOBlO_C7gGS2YANZWP-O3JdTo5HZn8AZ1iUKw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70923657</pqid></control><display><type>article</type><title>Plasma viscosity, fibrinogen and the metabolic syndrome: effect of obesity and cardiorespiratory fitness</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Carroll, S ; Cooke, C B ; Butterly, R J</creator><creatorcontrib>Carroll, S ; Cooke, C B ; Butterly, R J</creatorcontrib><description>The association between both plasma viscosity and fibrinogen concentration with clustering of metabolic risk markers was examined within a cross-sectional study of employed middle-aged men. Analyses were performed on a subsample of 629 non-smokers (46.7 ± 7.8 years) without diabetes. The effect of obesity and cardiorespiratory fitness on these haemorheological parameters and their association with the metabolic syndrome was also investigated. The cohort was grouped by the number of metabolic markers present. Metabolic markers included high-density lipoprotein-cholesterol (&lt; 1.13 mmol/l), triglycerides (≥ 1.805 mmol/l), glucose (≥ 5.5 mmol/l) and diastolic blood pressure (≥ 90 mmHg). The age-adjusted odds ratio for hyperviscosity (≥ 1.67 mPa/s) was 2.08 [95% confidence interval (CI), 1.06-4.05; P = 0.031] for the subjects with the metabolic syndrome (three or more metabolic markers) when compared with those with no metabolic abnormalities. The comparable age-adjusted odds ratio for hyperfibrinogenaemia (≥ 3.47 g/l) was non-significantly higher at 1.69 (95% CI, 0.87-3.27; P = 0.119). The mean age-adjusted plasma viscosity level and the prevalence of hyperviscosity increased significantly from 1.629 to 1.692 mPa/s (P = 0.0005) and from 21.0 to 36.0% with accumulating metabolic markers (P = 0.006). Plasma viscosity and fibrinogen concentration both increased with higher quartiles of skinfolds (P = 0.003 and P = 0.01, respectively) following adjustment for age, lipids and leucocyte count. Plasma viscosity was also significantly lower with higher levels of predicted maximum oxygen consumption ( o2max) (P = 0.0005). The odds ratio for hyperviscosity in subjects with the metabolic syndrome as compared with those with no metabolic markers was attenuated following adjustment for age, sum of skinfolds and predicted maximum oxygen consumption ( o2max) (1.44; 95% CI, 0.72-2.90; P = 0.307). These cross-sectional results suggest that plasma viscosity is associated with increased clustering of metabolic markers in middle-aged men of high socio-economic status. Obesity and poor cardiorespiratory fitness may be important in the development of haemorheological abnormalities associated with the metabolic syndrome.</description><identifier>ISSN: 0957-5235</identifier><identifier>EISSN: 1473-5733</identifier><identifier>DOI: 10.1097/00001721-200011010-00008</identifier><identifier>PMID: 10691101</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Adult ; Afibrinogenemia - blood ; Biological and medical sciences ; Biomarkers - blood ; Blood Viscosity - physiology ; Cardiology. Vascular system ; Cohort Studies ; Coronary heart disease ; Cross-Sectional Studies ; European Continental Ancestry Group ; Fibrinogen - analysis ; Heart ; Humans ; Male ; Medical sciences ; Middle Aged ; Myocardial Ischemia - blood ; Obesity - blood ; Oxygen Consumption ; Physical Fitness ; Risk Factors ; Syndrome</subject><ispartof>Blood coagulation &amp; fibrinolysis, 2000-01, Vol.11 (1), p.71-78</ispartof><rights>2000 Lippincott Williams &amp; Wilkins, Inc.</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3858-740473ccc129f669452b1c1716c95b69decd8546172c341a6cb96d4b7874c2593</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1270473$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10691101$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carroll, S</creatorcontrib><creatorcontrib>Cooke, C B</creatorcontrib><creatorcontrib>Butterly, R J</creatorcontrib><title>Plasma viscosity, fibrinogen and the metabolic syndrome: effect of obesity and cardiorespiratory fitness</title><title>Blood coagulation &amp; fibrinolysis</title><addtitle>Blood Coagul Fibrinolysis</addtitle><description>The association between both plasma viscosity and fibrinogen concentration with clustering of metabolic risk markers was examined within a cross-sectional study of employed middle-aged men. Analyses were performed on a subsample of 629 non-smokers (46.7 ± 7.8 years) without diabetes. The effect of obesity and cardiorespiratory fitness on these haemorheological parameters and their association with the metabolic syndrome was also investigated. The cohort was grouped by the number of metabolic markers present. Metabolic markers included high-density lipoprotein-cholesterol (&lt; 1.13 mmol/l), triglycerides (≥ 1.805 mmol/l), glucose (≥ 5.5 mmol/l) and diastolic blood pressure (≥ 90 mmHg). The age-adjusted odds ratio for hyperviscosity (≥ 1.67 mPa/s) was 2.08 [95% confidence interval (CI), 1.06-4.05; P = 0.031] for the subjects with the metabolic syndrome (three or more metabolic markers) when compared with those with no metabolic abnormalities. The comparable age-adjusted odds ratio for hyperfibrinogenaemia (≥ 3.47 g/l) was non-significantly higher at 1.69 (95% CI, 0.87-3.27; P = 0.119). The mean age-adjusted plasma viscosity level and the prevalence of hyperviscosity increased significantly from 1.629 to 1.692 mPa/s (P = 0.0005) and from 21.0 to 36.0% with accumulating metabolic markers (P = 0.006). Plasma viscosity and fibrinogen concentration both increased with higher quartiles of skinfolds (P = 0.003 and P = 0.01, respectively) following adjustment for age, lipids and leucocyte count. Plasma viscosity was also significantly lower with higher levels of predicted maximum oxygen consumption ( o2max) (P = 0.0005). The odds ratio for hyperviscosity in subjects with the metabolic syndrome as compared with those with no metabolic markers was attenuated following adjustment for age, sum of skinfolds and predicted maximum oxygen consumption ( o2max) (1.44; 95% CI, 0.72-2.90; P = 0.307). These cross-sectional results suggest that plasma viscosity is associated with increased clustering of metabolic markers in middle-aged men of high socio-economic status. Obesity and poor cardiorespiratory fitness may be important in the development of haemorheological abnormalities associated with the metabolic syndrome.</description><subject>Adult</subject><subject>Afibrinogenemia - blood</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Blood Viscosity - physiology</subject><subject>Cardiology. Vascular system</subject><subject>Cohort Studies</subject><subject>Coronary heart disease</subject><subject>Cross-Sectional Studies</subject><subject>European Continental Ancestry Group</subject><subject>Fibrinogen - analysis</subject><subject>Heart</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Ischemia - blood</subject><subject>Obesity - blood</subject><subject>Oxygen Consumption</subject><subject>Physical Fitness</subject><subject>Risk Factors</subject><subject>Syndrome</subject><issn>0957-5235</issn><issn>1473-5733</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU1v1DAQhi0EotuFv4B8qDiRYsdfMTdU0Q-pEhzgbDnOhDV14sX2ttp_j9PdFvBlrNHzzuh9ByFMyTklWn0k9VHV0qZdPpRQ0iyt7gVaUa5YIxRjL9GKaKEa0TJxgk5z_lUJxjv1Gp1QIvUiW6HNt2DzZPG9zy5mX_Yf8Oj75Of4E2Zs5wGXDeAJiu1j8A7n_TykOMEnDOMIruA44tjDonyknU2Djwny1idbYtrXcWWGnN-gV6MNGd4e6xr9uPzy_eK6uf16dXPx-bZxrBNdozipBpxztNWjlJqLtqeOKiqdFr3UA7ihE1xW945xaqXrtRx4rzrFXSs0W6P3h7nbFH_vIBczVWsQgp0h7rJRRLdM1oDWqDuALsWcE4xmm_xk095QYpaUzVPK5jnlx1ZXpe-OO3b9BMM_wkOsFTg7AjY7G8ZkZ-fzX65Vi8uK8QP2EEOBlO_C7gGS2YANZWP-O3JdTo5HZn8AZ1iUKw</recordid><startdate>200001</startdate><enddate>200001</enddate><creator>Carroll, S</creator><creator>Cooke, C B</creator><creator>Butterly, R J</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><general>The Scientist</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200001</creationdate><title>Plasma viscosity, fibrinogen and the metabolic syndrome: effect of obesity and cardiorespiratory fitness</title><author>Carroll, S ; Cooke, C B ; Butterly, R J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3858-740473ccc129f669452b1c1716c95b69decd8546172c341a6cb96d4b7874c2593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Afibrinogenemia - blood</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Blood Viscosity - physiology</topic><topic>Cardiology. Vascular system</topic><topic>Cohort Studies</topic><topic>Coronary heart disease</topic><topic>Cross-Sectional Studies</topic><topic>European Continental Ancestry Group</topic><topic>Fibrinogen - analysis</topic><topic>Heart</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Ischemia - blood</topic><topic>Obesity - blood</topic><topic>Oxygen Consumption</topic><topic>Physical Fitness</topic><topic>Risk Factors</topic><topic>Syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carroll, S</creatorcontrib><creatorcontrib>Cooke, C B</creatorcontrib><creatorcontrib>Butterly, R J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood coagulation &amp; fibrinolysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carroll, S</au><au>Cooke, C B</au><au>Butterly, R J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma viscosity, fibrinogen and the metabolic syndrome: effect of obesity and cardiorespiratory fitness</atitle><jtitle>Blood coagulation &amp; fibrinolysis</jtitle><addtitle>Blood Coagul Fibrinolysis</addtitle><date>2000-01</date><risdate>2000</risdate><volume>11</volume><issue>1</issue><spage>71</spage><epage>78</epage><pages>71-78</pages><issn>0957-5235</issn><eissn>1473-5733</eissn><abstract>The association between both plasma viscosity and fibrinogen concentration with clustering of metabolic risk markers was examined within a cross-sectional study of employed middle-aged men. Analyses were performed on a subsample of 629 non-smokers (46.7 ± 7.8 years) without diabetes. The effect of obesity and cardiorespiratory fitness on these haemorheological parameters and their association with the metabolic syndrome was also investigated. The cohort was grouped by the number of metabolic markers present. Metabolic markers included high-density lipoprotein-cholesterol (&lt; 1.13 mmol/l), triglycerides (≥ 1.805 mmol/l), glucose (≥ 5.5 mmol/l) and diastolic blood pressure (≥ 90 mmHg). The age-adjusted odds ratio for hyperviscosity (≥ 1.67 mPa/s) was 2.08 [95% confidence interval (CI), 1.06-4.05; P = 0.031] for the subjects with the metabolic syndrome (three or more metabolic markers) when compared with those with no metabolic abnormalities. The comparable age-adjusted odds ratio for hyperfibrinogenaemia (≥ 3.47 g/l) was non-significantly higher at 1.69 (95% CI, 0.87-3.27; P = 0.119). The mean age-adjusted plasma viscosity level and the prevalence of hyperviscosity increased significantly from 1.629 to 1.692 mPa/s (P = 0.0005) and from 21.0 to 36.0% with accumulating metabolic markers (P = 0.006). Plasma viscosity and fibrinogen concentration both increased with higher quartiles of skinfolds (P = 0.003 and P = 0.01, respectively) following adjustment for age, lipids and leucocyte count. Plasma viscosity was also significantly lower with higher levels of predicted maximum oxygen consumption ( o2max) (P = 0.0005). The odds ratio for hyperviscosity in subjects with the metabolic syndrome as compared with those with no metabolic markers was attenuated following adjustment for age, sum of skinfolds and predicted maximum oxygen consumption ( o2max) (1.44; 95% CI, 0.72-2.90; P = 0.307). These cross-sectional results suggest that plasma viscosity is associated with increased clustering of metabolic markers in middle-aged men of high socio-economic status. Obesity and poor cardiorespiratory fitness may be important in the development of haemorheological abnormalities associated with the metabolic syndrome.</abstract><cop>Philadelphia, PA</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>10691101</pmid><doi>10.1097/00001721-200011010-00008</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0957-5235
ispartof Blood coagulation & fibrinolysis, 2000-01, Vol.11 (1), p.71-78
issn 0957-5235
1473-5733
language eng
recordid cdi_proquest_miscellaneous_70923657
source MEDLINE; Journals@Ovid Complete
subjects Adult
Afibrinogenemia - blood
Biological and medical sciences
Biomarkers - blood
Blood Viscosity - physiology
Cardiology. Vascular system
Cohort Studies
Coronary heart disease
Cross-Sectional Studies
European Continental Ancestry Group
Fibrinogen - analysis
Heart
Humans
Male
Medical sciences
Middle Aged
Myocardial Ischemia - blood
Obesity - blood
Oxygen Consumption
Physical Fitness
Risk Factors
Syndrome
title Plasma viscosity, fibrinogen and the metabolic syndrome: effect of obesity and cardiorespiratory fitness
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A19%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20viscosity,%20fibrinogen%20and%20the%20metabolic%20syndrome:%20effect%20of%20obesity%20and%20cardiorespiratory%20fitness&rft.jtitle=Blood%20coagulation%20&%20fibrinolysis&rft.au=Carroll,%20S&rft.date=2000-01&rft.volume=11&rft.issue=1&rft.spage=71&rft.epage=78&rft.pages=71-78&rft.issn=0957-5235&rft.eissn=1473-5733&rft_id=info:doi/10.1097/00001721-200011010-00008&rft_dat=%3Cproquest_cross%3E70923657%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70923657&rft_id=info:pmid/10691101&rfr_iscdi=true